CETIRIZINE HYDROCHLORIDE MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Cetirizine Hydrochloride Market - Overview Global Cetirizine Hydrochloride Market, by Dosage Form (Tablet, Syrup, and Solution), by Age Group (Adult and Pediatric), by Application (Allergic Rhinitis, Allergic Conjunctivitis, Eczema, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Retail Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 1,100 million in 2017, and is projected to exhibit a CAGR of 3.2% over the forecast period (2018 – 2026), as highlighted in a new report published by . Increasing regulatory approvals for novel cetirizine formulation to augment the market growth The cetirizine hydrochloride market is expected to gain significant traction over the forecast period. This is owing to the pharmaceutical companies operating in the market that are focused on developing novel therapies. Such developments extend the applications of cetirizine hydrochloride for treating eye allergies and ocular diseases. For instance, in May 2017, the FDA approved the ophthalmic solution named Zerviate developed by Aciex Therapeutics, Inc., for topical application of the second-generation histamine-1 (H1) receptor antagonist for use in treating ocular itching associated with allergic conjunctivitis. The FDA approval was based on the New Drug Application providing data that demonstrated the efficacy, safety, and tolerability of cetirizine ophthalmic solution in phase 3 phase clinical trials using the conjunctival antigen challenge (CAC) model. Browse Research Reports: https://www.coherentmarketinsights.com/marketinsight/cetirizine-hydrochloride-market-2069 © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Furthermore, in September 2017, Nicox Ophthalmics, Inc., a subsidiary of Nicox S.A. entered into an exclusive licensing agreement with Eyevance Pharmaceuticals LLC, for the commercialization of Zerviatetm (cetirizine ophthalmic solution) 0.24%, in the US, thereby pursuing the expansion of the product into additional markets. Browse 28 Market Data Tables and 22 Figures spread through 148 Pages and in-depth TOC on “Cetirizine Hydrochloride Market - Global Forecast to 2026, by Dosage Form (Tablet, Syrup, and Solution), by Age Group (Adult and Pediatric), by Application (Allergic Rhinitis, Allergic Conjunctivitis, Eczema, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Retail Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa).” The market players are adopting strategies such as mergers and acquisitions to enhance the product portfolio by gaining market access of cetirizine hydrochloride pipeline products and to further address major segments of the ophthalmic market, including allergy and inflammation. For instance, in 2014, Nicox S.A. acquired Aciex Therapeutics, Inc., the U.S. based ophthalmic development pharmaceutical company with a strong late stage therapeutic pipeline in ophthalmology, thereby diversifying the product portfolio and gaining commercial rights of the product in the U.S. Also, in 2017, the pharmaceutical company Strides Shasun, headquartered in Bangalore received approval for allergy drug Cetirizine Hydrochloride in the U.S. Under the agreement, the company will manufacture the product at its flagship facility at Bangalore. The product is marketed by Strides Pharma Inc. in the US market. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/2069 © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Key Takeaways of the Cetirizine Hydrochloride Market: The global cetirizine hydrochloride market is expected to exhibit a CAGR of 3.2% over the forecast period, owing to the launch and approval of products with novel formulations and increasing incidence of allergic rhinitis Among dosage form, the tablet segment holds a dominant position in the cetirizine hydrochloride market, as they provide a cheaper alternative than the other dosage forms along with higher shelf-life, better absorption, and dissolution Among age group, the pediatric segment holds a dominant position in the cetirizine hydrochloride market, owing to the high rate of disease diagnosis among the pediatric population, as the group is highly susceptibility to allergic disease Among application, the hay fever segment holds a dominant position in the cetirizine hydrochloride market, owing to the high prevalence of the condition in North America, Europe, and Asia Pacific. Some of the major players operating in the global cetirizine hydrochloride market include, Johnson and Johnson, Mylan, Inc., Nicox S.A., Strides Shasun, Apotex, Inc., Teva UK Limited, Aurobindo Pharma Limited, Jubilant Life Sciences, Tris Pharma, Inc., and Cipla Ltd
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/2069 © Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.
SERVICES INDUSTRY ANALYSIS
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT CMI SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
Global Leading Equipment and System Manufacturers Marketing Consultancies and the Advertising Industry Component Providers and System Integrators
Private and Government organization
Distributors, Retailors and Value Added Resellers
Outsourcing Companies
Healthcare IT Solutions Developers
Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY STUDIES
Insights Published Per Year
GLOBAL REPORTS
150+
Consulting Projects Till Date
COUNTRY ANALYSIS CONSULT PROJECTS
125+
Clients Worldwide Per Year
110+
SURVEY RESEARCH
EXCEL FORECAST DATABASE
CUSTOMIZED SOLUTIONS
COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702
© Coherent market Insights. All Rights Reserved